Aghazadeh Behzad — insider trades

Stock trades Aghazadeh Behzad reported on SEC Form 4 at SCTX Scribe Therapeutics, Inc..

• Jul 28, 2026: bought 2,391,238 shares of SCTX Scribe Therapeutics, Inc. ($36.3M)